Last update:
Oncology & Cancer news
Oncology & Cancer
Unlocking the potential of patient-derived organoids for personalized sarcoma treatment
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify ...
7 hours ago
0
8
Oncology & Cancer
Identifying sex-based differences in immune responses against tumors
Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of ...
6 hours ago
0
0
Antidepressant shows promise for treating brain tumors
Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, ...
15 hours ago
0
13
Study: Inflammatory cells in tumor microenvironment transform prostate cancer cells into treatment-resistant cells
Treatment-resistant cells are a challenge related to prostate cancer and many other cancers, which arises as the disease progresses. However, these resistance mechanisms are not yet fully understood.
7 hours ago
0
0
Higher incarceration rates linked to increased cancer mortality rates
Higher incarceration rates are associated with increased county- and state-level cancer mortality rates, according to a study published online Sept. 17 in the Journal of the National Cancer Institute.
7 hours ago
0
0
Tivozanib has efficacy in advanced renal cell carcinoma post-immune checkpoint inhibitor therapy
For patients with metastatic renal cell carcinoma (mRCC) and progression during or after one to two prior lines of therapy, including one immune checkpoint inhibitor (ICI), tivozanib has efficacy, according to a study published ...
7 hours ago
0
0
Vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma
A team of researchers from City of Hope and The University of Texas M.D. Anderson Cancer Center has reported safety and efficacy results from a Phase 1 trial that featured a personalized vaccine to treat lymphoplasmacytic ...
Sep 19, 2024
0
5
Low oxygen levels in tumors could enhance some of the body's immune responses against cancer
In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition known as hypoxia. Hypoxia arises as tumors grow rapidly, outpacing their blood supply due to the ...
Sep 19, 2024
0
28
Researchers integrate individualized daily irradiation in proton therapy tumor treatment
In the treatment of cancer patients, irradiation can be adapted anew each day to the position of the tumor and conditions in the body. Researchers at the Paul Scherrer Institute PSI have now, for the first time, integrated ...
Sep 19, 2024
0
14
New combination treatment brings hope to patients with advanced bladder cancer
Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients with locally advanced or metastatic bladder cancer. The results, published ...
Sep 19, 2024
0
1
New prostate biopsy technique lowers infection risk
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators has shown that a newer technique for collecting prostate biopsy samples reduced the risk of infection compared with ...
Sep 19, 2024
0
16
Considering race in colon cancer prediction algorithms reduces disparities, researchers find
Taking race into account when developing tools to predict a patient's risk of colorectal cancer leads to more accurate predictions when compared with race-blind algorithms, researchers find.
Sep 19, 2024
0
0
Study confirms fibrosis as a prognostic indicator in the most common breast cancer
The most common breast cancer is HER2-negative, so called because it has low amounts of one of the proteins that contribute to tumor cell growth, HER2. Despite this common trait, the development of HER2-negative cancers varies ...
Sep 19, 2024
0
0
Germany-wide study establishes quality standards for looking into the tumor genome
Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a precise look into the genetic material of tumors, a molecular diagnostic tumor profile. A research ...
Sep 19, 2024
0
1
Study: Naldemedine prevents opioid-induced constipation in patients with cancer
Opioids, potent pain relievers for patients with cancer, frequently cause constipation, which is a significant issue. Researchers at University of Tsukuba revealed that administering naldemedine, which is a constipation medication, ...
Sep 19, 2024
0
0
Vulnerable patients have a decreased mortality risk when treated at commission on cancer-accredited hospitals
Vulnerable patients facing social, environmental, and economic disadvantages often experience worse cancer outcomes than other groups. Some of these disparities may be reduced by increasing access to hospitals accredited ...
Sep 19, 2024
0
0
Adjuvant durvalumab extends survival in small cell lung cancer
For patients with limited-stage small cell lung cancer, adjuvant therapy with durvalumab leads to significantly longer overall and progression-free survival, according to a study published online Sept. 13 in the New England ...
Sep 19, 2024
0
0
As blood cancer treatments evolve, so does the patient journey
Treatment for blood cancers is advancing, giving more options to people living with the disease.
Sep 19, 2024
0
21
Study reveals racial and socioeconomic disparities in lung cancer testing
A new Mount Sinai study published in the Journal of the National Cancer Institute on September 10, 2024, has found that people with lung cancer face big differences in getting important tests based on their race and income. ...
Sep 19, 2024
0
0
Non-invasive method can help predict survival in patients with liver cancer
Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of cancer-related death worldwide. For patients with an advanced form of HCC, there are different types of systemic ...
Sep 19, 2024
0
0
What you should know about prostate cancer screening
The prostate is a small gland in males that aids in reproduction. Prostate cancer is one of the most common types of cancer, and when it's detected early, often by a simple blood test, it has the best chance for successful ...
Sep 19, 2024
0
0
Palliative medicine for cancer patients explained
Patients undergoing cancer treatments often use palliative medicine to cope with nausea, fatigue and other bothersome symptoms.
Sep 19, 2024
0
0
Tailoring radiation therapy for brain cancer treatment: A personal investigation
A University of Ottawa neuroscientist's personal battle with cancer has inspired new research geared toward tailoring radiation treatment to reduce damage to the brain. The research is published in the journal Scientific ...
Sep 18, 2024
0
13
Breast and ovarian cancer newly linked to thousands of gene variants
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person's risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalized care.
Sep 18, 2024
0
16
Changes in chromosomes of cancer cells may increase their sensitivity to anti-cancer drugs
Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University, in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of cells with ...
Sep 18, 2024
0
3
